FDA Reporting Transparency and Accountability Act This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.
Computers and information technologyCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Government buildings, facilities, and propertyGovernment employee pay, benefits, personnel managementGovernment information and archivesLicensing and registrationsPerformance measurementPrescription drugsPublic contracts and procurementPublic participation and lobbyingUser charges and fees
A bill to increase reporting transparency and accountability with respect to Food and Drug Administration user fees.
USA115th CongressS-1062| Senate
| Updated: 5/4/2017
FDA Reporting Transparency and Accountability Act This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.
Computers and information technologyCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Government buildings, facilities, and propertyGovernment employee pay, benefits, personnel managementGovernment information and archivesLicensing and registrationsPerformance measurementPrescription drugsPublic contracts and procurementPublic participation and lobbyingUser charges and fees